Skip to main content

Table 2 Final diagnoses

From: Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis

  Male (n = 167) Female (n = 107) All (n = 274)
No amyloidosis 80 (48%) 62 (58%) 142 (52%)
 TTR mutation 22 (28%) 31 (50%) 53 (37%)
 No TTR mutation 58 (72%) 31 (50%) 89 (63%)
Amyloidosis 87 (52%) 45 (42%) 132 (48%)
 ATTRv amyloidosis 82 (94%) 41 (91%) 123 (93%)
 Dx before 2006 10 (12%) 9 (22%) 19 (16%)
 ATTRV30M 69 (84%) 31 (76%) 100 (81%)
 Other mutationa 3 (4%) 1 (2%) 4 (3%)
 ATTRwt amyloidosis 1 (1%) 0 (0%) 1 (1%)
 AL amyloidosis 4 (5%) 3 (7%) 7 (5%)
 Localized 3 (75%) 3 (100%) 6 (86%)
 Systemic 1 (25%) 0 (0%) 1 (14%)
 Gelsolin amyloidosis 0 (0%) 1 (2%) 1 (1%)
  1. aH88R, A45S, V122I and A97S; AL, amyloid light chain; ATTRv, variant transthyretin amyloidosis; ATTRV30M, transthyretin amyloidosis caused by the TTR V30M mutation; ATTRwt, wild-type transthyretin amyloidosis; Dx, diagnosis; TTR, transthyretin gene. Percentages are shown as column percentage within each heading/subheading